South Korea

FDA Grants Orphan Drug Status to GC Biopharma's Thrombocytopenic Purpura Drug in South Korea

When designated as an orphan drug, there are incentives such as tax credits for clinical development costs and exemptions from PDUFA user fees Initial Pedi...

 October 06, 2023 | News

LOTTE BIOLOGICS Acquires Land in Songdo with Incheon Free Economic Zone Authority

Construction of a Bio Plant with a total production capacity of 360 kL at Songdo's Block KI20, Zone 11 by 2030 Aims to secure capabilities of an interna...

 October 05, 2023 | News

Chime Biologics Partners with Korea Kings Pharm for Biosimilar Launch

Chime Biologics, a leading CDMO that enables its partners' success in biologics, announced a strategic cooperation with Kings Pharm. According to the agre...

 September 26, 2023 | News

Chime Biologics Partners with Panolos Bioscience for Multi-specific Protein Development

Chime Biologics, a leading CDMO that enables biologic therapeutics development announced a strategic cooperation agreement with Panolos Bioscience, a South...

 September 25, 2023 | News

'Bayer For Her' Supporting 365 Days Conversations of Care to More Women in Asia

Bayer Pharmaceuticals Division in Asia/Pacific announced in conjunction with World Contraception Day, the inception of its 'Bayer For Her' region...

 September 25, 2023 | News

Kai Health’s Embryo Assessment AI Achieves European Medical Device Certification

Kai Health's innovative solution utilizes artificial intelligence to objectively analyze embryo images, providing predictions of embryo viability. This bre...

 September 22, 2023 | News

Everest Medicines Collaborates with Kezar Life Sciences to Develop Zetomipzomib in Greater China and other Asian Markets

"We are glad to form a partnership with Kezar through our cooperation on zetomipzomib, which will add to our existing renal pipeline, and help solidify Eve...

 September 21, 2023 | News

SomaLogic and Korea’s DNA Link Join Forces to Expand SomaScan® Platform in Asia-Pacific Proteomics Market

SomaLogic Inc., (Nasdaq:SLGC), a leader in data-driven proteomics technology,  announced its partnership with DNA Link, an innovator in personalized a...

 September 20, 2023 | News

South Korea's ST Pharm Marks Milestone with Oligonucleotide Facility Ceremony

To diversify its operational scope, the new facility will be designed to accommodate different scales of production. Initially, it will introduce three new...

 September 19, 2023 | News

Samsung Biologics Expands Agreement with Bristol Myers Squibb to Manufacture Cancer Drug

Bristol Myers Squibb and Samsung Biologics have an existing manufacturing agreement for a commercial antibody cancer drug and have expanded the s...

 September 18, 2023 | News

Oscotec/ADEL Receives FDA Clearance for Alzheimer's Treatment IND Application (ADEL-Y01)

Oscotec and ADEL are jointly developing a novel disease-modifying immunotherapy agent (ADEL-Y01) targeting tau protein accumulation in the AD brain. ADEL-Y...

 September 15, 2023 | News

MGI and Bio-Medical Science Partner to Provide Advanced Sequencing Solutions to South Korea

"This MOU marks a key milestone for the development of genomics in South Korea as we introduce localized, high-quality and cost-effective solutio...

 September 14, 2023 | News

Lunit Study Backs AI as Effective Alternative to Single Human Reader in European Double Reading System

 Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, is spearheading a transformative change in...

 September 12, 2023 | News

Serbian Prime Minister Visits SK Bioscience for Vaccine Localization Partnership

  Ana Brnabić, Prime Minister of Serbia visited the headquarters of SK bioscience. SK bioscience has signed a Memorandum of Understanding with th...

 September 11, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close